Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study-Reference-Cited by-同舟云学术

Impact of pathological tumor response after CROSS neoadjuvant chemoradiotherapy followed by surgery on long-term outcome of esophageal cancer: a population-based study

Published:2021-01-25 Issue:4 Volume:60 Page:497-504
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Al-Kaabi Ali¹^ORCID,van der Post Rachel S.²,van der Werf Leonie R.³,Wijnhoven Bas P. L.³,Rosman Camiel⁴,Hulshof Maarten C. C. M.⁵,van Laarhoven Hanneke W. M.⁶^ORCID,Verhoeven Rob H. A.⁴⁷,Siersema Peter D.¹^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands

2. Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands

3. Department of Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands

4. Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands

5. Department of Radiotherapy, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

6. Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

7. Department of Research & Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2020.1870246

Reference43 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Predicting the Future Burden of Esophageal Cancer by Histological Subtype: International Trends in Incidence up to 2030

3. Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

4. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

5. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a prognostic nomogram for esophageal squamous cell carcinoma patients received radiotherapy based on clinical risk factors;Frontiers in Oncology;2024-08-22

2. Impact of the interval between neoadjuvant immunotherapy and surgery on prognosis in esophageal squamous cell carcinoma (ESCC): a real-world study;Cancer Immunology, Immunotherapy;2024-08-06

3. A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma;BMC Cancer;2024-04-12

4. Treatment of local recurrence of esophageal cancer following Ivor‐Lewis esophagectomy—Experiences of a high‐volume center;World Journal of Surgery;2024-03-30

5. Adjuvant therapy provides no additional recurrence-free benefit for esophageal squamous cell carcinoma patients after neoadjuvant chemoimmunotherapy and surgery: a multi-center propensity score match study;Frontiers in Immunology;2024-02-05